Equine Potomavac (Canada)

Ehrlichia Risticii Bacterin

PHF

DESCRIPTION: EQUINE POTOMAVAC™ is a liquid suspension of inactivated Ehrlichia risticii. Safety and efficacy of this product have been demonstrated in controlled vaccination challenge tests and in thorough field evaluations.

INDICATIONS: Recommended for the vaccination of healthy horses as an aid in the prevention of Potomac Horse Fever (equine monocytic ehrlichiosis) caused by E. risticii.

DOSAGE: For primary vaccination, aseptically inject 1 mL (1 dose) intramuscularly into healthy horses 3 months of age or older. Revaccinate with a second 1 mL dose 3 to 4 weeks later. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Do not freeze. Use entire contents when first opened. Shake well before using. Contains gentamicin and thimerosal as preservatives. Do not vaccinate within 21 days prior to slaughter. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results.

SOLD TO VETERINARIANS ONLY

For Veterinary Use Only.

Potomavac™ is a trademark of MERIAL.

Manufactured By MERIAL INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 3V1

CPN: 1182019.3